Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov
Study Type: Interventional
Phase: Phase II
Study Start Date: 12/01/2016
Study Completion Date: 12/31/2021
The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).